RECEPTOR SPECIFIC ENKEPHALIN ANALOGUES
受体特异性脑啡肽类似物
基本信息
- 批准号:2263725
- 负责人:
- 金额:$ 18.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-04-01 至 1994-09-30
- 项目状态:已结题
- 来源:
- 关键词:autoradiography behavioral medicine binding proteins brain metabolism chemical structure function conformation drug addiction antagonist drug metabolism drug quality /standard enkephalins guinea pigs hamsters high performance liquid chromatography hormone receptor hormone regulation /control mechanism ion exchange chromatography laboratory mouse laboratory rabbit laboratory rat narcotic antagonists neuropeptide receptor neuropeptides neuropharmacology nuclear magnetic resonance spectroscopy opiate alkaloid peptide analog peptide chemical synthesis protein engineering radiotracer synthetic peptide
项目摘要
We propose to develop a series of cyclic and otherwise conformationally
restricted peptide analogues which have high receptor selectivity, high
agonist or antagonist potency, high stability in vivo, and prolonged
activity for delta and mu opioid receptors. For this purpose, our program
utilizes a multidisciplinary approach combining modern synthetic amino acid
and peptide chemistry, conformational analysis, dynamics, and peptide drug
design, with biochemical, biophysical, physiological, and behavior
pharmacology. Our specific aims include: 1) design, synthesis and
evaluation of novel enkephalin analogues with delta opioid receptor agonist
activity and selectivity; 2) development of delta opioid receptor
antagonists with high selectivity; 3) design, synthesis and evaluation of
cycli, conformationally-constrained somatostatin-like peptides with little
or no somatostatin activity, but with high potency and specificity for mu
opioid receptors; 4) examination in detail of the conformational and
dynamic properties of the most potent and selective analogues from 1, 2,
and 3 to obtain insight into the rational design of more selective or
potent analogues using modern graphics and computational methods; 5) to
examine in detail the binding activities of these compounds at mu and delta
opioid receptors (the most selective analogues with be radiolabeled and
receptor localized in the brain by modern autoradiographic methods); 6) to
obtain a comprehensive evaluation of the opioid agonist and antagonist in
vitro and in vivo activities of the analogues we have prepared and compare
these activities with standard drugs; and 7) to use the above results to
design more specific and more potent analogues for the delta and mu
receptor. The long term goals of this research are to develop an
understanding of the physiological roles of the various opioid receptors,
and to develop ligands for these receptors which can be used for the
treatment of disease.
我们建议发展一系列旋回和其他构象
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
使用高选择性双青霉胺环状脑啡肽类似物对大鼠大脑中 δ 阿片受体进行放射自显影定位。
- DOI:10.1016/0014-2999(85)90770-8
- 发表时间:1985
- 期刊:
- 影响因子:5
- 作者:Gulya,K;Gehlert,DR;Wamsley,JK;Mosberg,HI;Hruby,VJ;Duckles,SP;Yamamura,HI
- 通讯作者:Yamamura,HI
Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog.
使用高选择性双青霉胺环状脑啡肽类似物对大鼠大脑中 δ 阿片受体进行光显微放射自显影定位。
- DOI:
- 发表时间:1986
- 期刊:
- 影响因子:0
- 作者:Gulya,K;Gehlert,DR;Wamsley,JK;Mosberg,H;Hruby,VJ;Yamamura,HI
- 通讯作者:Yamamura,HI
Opioid peptides: simultaneous delta agonism and mu antagonism in somatostatin analogues.
阿片肽:生长抑素类似物同时具有 δ 激动作用和 mu 拮抗作用。
- DOI:10.1016/s0196-9781(96)00242-2
- 发表时间:1997
- 期刊:
- 影响因子:3
- 作者:Bonner,GG;Davis,P;Stropova,D;Ferguson,R;Yamamura,HI;Porreca,F;Hruby,VJ
- 通讯作者:Hruby,VJ
Structure-activity analysis of five constrained somatostatin like peptides with opioid antagonist properties.
五种具有阿片拮抗剂特性的受限生长抑素样肽的结构活性分析。
- DOI:
- 发表时间:1987
- 期刊:
- 影响因子:0
- 作者:Wire,WS;Pelton,JT;Kazmierski,W;Hruby,VJ;Burks,TF;Shook,JE
- 通讯作者:Shook,JE
A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin.
δ 阿片受体的高亲和力、高选择性配体:[3H]-[D-Pen2、pCl-Phe4、d-Pen5]脑啡肽。
- DOI:10.1016/0024-3205(89)90154-9
- 发表时间:1989
- 期刊:
- 影响因子:6.1
- 作者:Vaughn,LK;Knapp,RJ;Toth,G;Wan,YP;Hruby,VJ;Yamamura,HI
- 通讯作者:Yamamura,HI
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Victor J Hruby其他文献
Victor J Hruby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Victor J Hruby', 18)}}的其他基金
New Modalities for the Treatment of Pain and Drug Abuse
治疗疼痛和药物滥用的新方法
- 批准号:
9073233 - 财政年份:2017
- 资助金额:
$ 18.56万 - 项目类别:
New Modalities for the Treatment of Pain and Drug Abuse
治疗疼痛和药物滥用的新方法
- 批准号:
9918285 - 财政年份:2017
- 资助金额:
$ 18.56万 - 项目类别:
Design of Novel Multivalent Ligands with Unique Biological Activity Profiles for Treatment of Prolonged and Neuropathic Pain without Toxicities
具有独特生物活性特征的新型多价配体的设计,用于无毒治疗长期疼痛和神经性疼痛
- 批准号:
9073237 - 财政年份:2017
- 资助金额:
$ 18.56万 - 项目类别:
DESIGN OF NOVEL LIGANDS WITH UNIQUE BIOLOGICAL PROFILES FOR NEUROPATHIC PAIN AND
设计具有独特生物特征的新型配体,用于治疗神经病理性疼痛和
- 批准号:
8025975 - 财政年份:2010
- 资助金额:
$ 18.56万 - 项目类别:
Design of Novel Opiod Peptide Ligands With Unique Biological Profiles
具有独特生物学特征的新型阿片肽配体的设计
- 批准号:
7513577 - 财政年份:2007
- 资助金额:
$ 18.56万 - 项目类别:
相似海外基金
Society of Behavioral Medicine 2023 Annual Meeting & Scientific Sessions
行为医学学会2023年年会
- 批准号:
10681958 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Society of Behavioral Medicine 2023 Annual Meeting & Scientific Sessions
行为医学学会2023年年会
- 批准号:
10852680 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Society of Behavioral Medicine 2022 Annual Meeting & Scientific Sessions
行为医学学会2022年年会
- 批准号:
10661113 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别:
Supplement to Society of Behavioral Medicine 2021 Annual Meeting & Scientific Sessions
行为医学学会2021年年会增刊
- 批准号:
10393765 - 财政年份:2021
- 资助金额:
$ 18.56万 - 项目类别:
Society of Behavioral Medicine 2019 Annual Meeting & Scientific Sessions
行为医学学会2019年年会
- 批准号:
9755691 - 财政年份:2019
- 资助金额:
$ 18.56万 - 项目类别:
Academy of Behavioral Medicine Research Annual Conference
行为医学研究学会年会
- 批准号:
9329808 - 财政年份:2017
- 资助金额:
$ 18.56万 - 项目类别:
Society of Behavioral Medicine 2016 Annual Meeting & Scientific Sessions
行为医学学会2016年年会
- 批准号:
9121875 - 财政年份:2016
- 资助金额:
$ 18.56万 - 项目类别:
Society of Behavioral Medicine 2014 Annual Meeting and Scientific Sessions
行为医学学会 2014 年年会和科学会议
- 批准号:
8719416 - 财政年份:2014
- 资助金额:
$ 18.56万 - 项目类别:
Society of Behavioral Medicine 2012 Annual Meeting and Scientific Sessions
行为医学学会 2012 年年会和科学会议
- 批准号:
8256997 - 财政年份:2012
- 资助金额:
$ 18.56万 - 项目类别:
11th International Congress of Behavioral Medicine (ICBM2010)
第十一届国际行为医学大会(ICBM2010)
- 批准号:
7805686 - 财政年份:2010
- 资助金额:
$ 18.56万 - 项目类别:














{{item.name}}会员




